PSI Webinar: Surrogacy
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
3 years
When I was employed as a Statistician in AstraZeneca 3 years ago, I didn’t know much about the pharmaceutical industry. I had just obtained my Master’s degree in Applied Statistics from Örebro University (Sweden) and my previous work experience in statistics was from part-time jobs in the field of economics, medicine and social studies. During my first year in AstraZeneca, I was mainly doing exploratory work to inform study design and assess the robustness of results from finished studies. This helped me to get familiar with the industry processes and what stands behind the clinical programmes design, regulatory submissions and commercialisation. Gradually, I gained more independence and responsibilities in designing studies, deciding on analysis approaches and communicating with external partners. I was promoted to a Senior Statistician after 2 years of working, which is my current role.
I would typically have 1-3 meetings a day with colleagues such as physicians, safety experts, data management experts, statistical programmers, medical writers and other study and project team members as well as external vendors and partners.
I would review project documents or outputs from vendors or team members or would work on drafting and finalizing internal documents or outputs. I would produce analyses for internal use or would do literature research for incorporating the best analyses approach in our study design.
I am doing something different every day and constantly developing different technical and soft skills. There are so many different sub-areas that a statistician can work on within a pharmaceutical company that it is easy to find something that you enjoy or explore other areas if you want to try something new. I also like the sense of importance in the work my colleagues and I do and cannot help but feel proud for contributing to the development of new and better medicines for patients.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The webinar will show how the estimand framework was applied in a Phase 3 trial in Alzheimer's disease.
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This webinar will discuss opportunities in applying causal inference methodology during the analysis of RCT data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This apprenticeship role offers a unique opportunity to learn and work in a global healthcare consultancy company alongside a team of statisticians, psychometricians and programmers.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.